These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 15030117

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Levosimendan.
    Figgitt DP, Gillies PS, Goa KL.
    Drugs; 2001; 61(5):613-27; discussion 628-9. PubMed ID: 11368286
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Hemodynamic effects of a continuous infusion of levosimendan in critically ill patients with cardiogenic shock requiring catecholamines.
    Delle Karth G, Buberl A, Geppert A, Neunteufl T, Huelsmann M, Kopp C, Nikfardjam M, Berger R, Heinz G.
    Acta Anaesthesiol Scand; 2003 Nov; 47(10):1251-6. PubMed ID: 14616323
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Levosimendan in acute decompensated heart failure: systematic review and meta-analysis.
    Ribeiro RA, Rohde LE, Polanczyk CA.
    Arq Bras Cardiol; 2010 Aug; 95(2):230-7. PubMed ID: 20549133
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. European experience on the practical use of levosimendan in patients with acute heart failure syndromes.
    Follath F, Franco F, Cardoso JS.
    Am J Cardiol; 2005 Sep 19; 96(6A):80G-5G. PubMed ID: 16181827
    [Abstract] [Full Text] [Related]

  • 54. Levosimendan and calcium sensitization of the contractile proteins in cardiac muscle: impact on heart failure.
    Kota B, Prasad AS, Economides C, Singh BN.
    J Cardiovasc Pharmacol Ther; 2008 Dec 19; 13(4):269-78. PubMed ID: 19087950
    [Abstract] [Full Text] [Related]

  • 55. [Hemodynamic effects of levosimendan compared with dobutamine in patients with low cardiac output after cardiac surgery].
    Alvarez J, Bouzada M, Fernández AL, Caruezo V, Taboada M, Rodríguez J, Ginesta V, Rubio J, García-Bengoechea JB, González-Juanatey JR.
    Rev Esp Cardiol; 2006 Apr 19; 59(4):338-45. PubMed ID: 16709386
    [Abstract] [Full Text] [Related]

  • 56. Successful use of levosimendan in a patient during cardiopulmonary bypass.
    Iriz E, Erer D, Unal Y, Zor H, Ozkose Z, Ozdogan ME.
    J Card Surg; 2007 Apr 19; 22(2):153-6. PubMed ID: 17338755
    [Abstract] [Full Text] [Related]

  • 57. Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease.
    Hummel J, Rücker G, Stiller B.
    Cochrane Database Syst Rev; 2017 Mar 06; 3(3):CD011312. PubMed ID: 28262914
    [Abstract] [Full Text] [Related]

  • 58. Hemodynamic effects of levosimendan in patients with low-output heart failure after cardiac surgery.
    Labriola C, Siro-Brigiani M, Carrata F, Santangelo E, Amantea B.
    Int J Clin Pharmacol Ther; 2004 Apr 06; 42(4):204-11. PubMed ID: 15124978
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Levosimendan: implications for clinicians.
    McBride BF, White CM.
    J Clin Pharmacol; 2003 Oct 06; 43(10):1071-81. PubMed ID: 14517189
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.